ResultsReply to Clarification- Financial results
Anthem Biosciences clarified FY26 results.
Anthem Biosciences LimitedANTHEM · Filed with the exchange
The reported PAT of INR 591.79 Cr was consistent across filings.
Consolidated EPS omission in XBRL was a clerical error, not impacting other financials.
A revised XBRL filing is being submitted.
No comments yet. Be the first.